Iridex (IRIX) Receivables - Other (2022 - 2023)
Iridex (IRIX) posted quarterly Receivables - Other of $3.8 million for Q2 2023, up 12.29% year-over-year from $3.4 million in Q2 2022, and up 8.17% quarter-over-quarter from $3.5 million in Q4 2022.
Iridex (IRIX) Receivables - Other (2022 - 2023) Analysis & Trends
Iridex's Receivables - Other history runs 2 years deep, the most recent figure standing at $3.8 million for Q2 2023.
- In Q2 2023, Receivables - Other rose 12.29% year-over-year to $3.8 million; the TTM figure through Apr 2023 stood at $3.8 million (up 12.29% YoY), while the FY2022 annual figure was $3.5 million, up 13.94% from the prior year.
- Receivables - Other for Q2 2023 stood at $3.8 million, up from $3.5 million in the prior quarter.
- The five-year high for Receivables - Other was $3.8 million in Q2 2023, with the low at $2.4 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Iridex | 13.27 Mn | 8.59 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 1, 2023 | 3.83 Mn |
| Apr 1, 2023 | 3.83 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Oct 1, 2022 | 3.59 Mn |
| Oct 1, 2022 | 3.59 Mn |
| Jul 2, 2022 | 2.43 Mn |
| Jul 2, 2022 | 2.43 Mn |
| Apr 2, 2022 | 3.41 Mn |
| Apr 2, 2022 | 3.41 Mn |
| Jan 1, 2022 | 3.11 Mn |
| Jan 1, 2022 | 3.11 Mn |